| abstract |
The present disclosure relates to obtaining a monoclonal antibody against TNF or antibody fragments, the nucleotide sequences encoding both the antibody and the variable domains thereof. Methods for cloning and producing the antibody. The disclosure also considered formulations that include the products described above, as well as kits and/or means for the implementation of treatment or diagnosis. Additionally, the disclosure relates to treatment or diagnostic procedures related to the antibody, and the uses for which it is required. |